The ASM submitted comments to the Centers for Disease Control on the Biennial Review of the Select Agent Regulations.
On March 27, 2015 the White House released a comprehensive plan that identifies critical actions to be taken by Federal departments and agencies to combat the rise of antibiotic-resistant bacteria.
The ASM sent a letter to Sylvia Mathews Burwell, Secretary of Health and Human Services, Department of Health and Human Services regarding CDC Biosafety recommendations.
The ASM submitted FY 2016 appropriations recommendations to the House and Senate Appropriations Committees.
The Office of Science and Technology Policy released a request for comment on regarding the impact that the Select Agent Regulations (SAR) have had on science, technology, and national security, and on the benefits, costs, and limitations of these regulations.
January 28, 2015 - ASM Statement on the President’s Proposed 2016 Budget to Combat Antibiotic-Resistant Bacteria
The ASM released a statement on the President’s Proposed 2016 Budget to Combat Antibiotic-Resistant Bacteria.
The ASM sent a letter to Senator Richard Durbin (D-IL) endorsing the bill which would provide a five percent increase in funding for biomedical research supported by the National Institutes of Health and other federal agencies involved in biomedical research.
The ASM sent a letter to members of Congress supporting passage of an FY 2015 Omnibus Appropriations bill to provide sustained and predictable federal funding for life science research and public health programs.
The ASM sent a letter to members of Congress supporting the Administration's $6.18 billion emergency funding request to combat the Ebola Virus outbreak.
October 29, 2014 - ASM Statement on CDC Interim Guidance on Monitoring and Movement of Persons with Suspected Ebola Contact
The ASM issued a statement regarding the Centers for Disease Control and Prevention new Interim Guidance on Monitoring and Movement of Persons with Suspected Ebola Contact.